# Integra Q3 2026 Earnings Report

> Integra reports Q3 revenue at $411.2M with Cincinnati flood impact.
- Title: Integra Q3 2026 Earnings Report · The Motley Fool | Shortify
- Summary: Integra reports Q3 revenue at $411.2M with Cincinnati flood impact. Integra's Q3 revenue grew 2.5% organically to $411.2M despite $7M Cincinnati flood…
- Keywords: integra, iart, q3 2026, earnings call, cincinnati flood, specialty surgery, neurosurgery, tissue reconstruction, surgimend, debt refinancing, full year 2026 revenue, adjusted eps
- Source: The Motley Fool — https://fool.com/earnings/call-transcripts/2026/10/21/integra-iart-q3-2026-earnings-call-transcript
- Author: Motley Fool Transcribing
- Published: 2026-10-21T16:57:54+00:00
- Read time: 2 min
- Topics: integra, iart, q3 2026, earnings call, cincinnati flood, specialty surgery, neurosurgery, tissue reconstruction, surgimend, debt refinancing, full year 2026 revenue, adjusted eps
## Q3 Revenue
Revenue reached $411.2 million, representing 2.5% organic growth despite $7 million headwind from Cincinnati facility disruption.
## Adjusted EPS
Adjusted earnings per share rose to $0.59 from $0.54 in prior year, reflecting revenue growth and cost reductions.
## Specialty Surgery
Specialty surgery revenue grew 4.2% organically driven by neurosurgery and international markets.
## Neurosurgery Growth
Neurosurgery organic revenue grew 6.5% with strong demand for CereLink, Certas Plus, Bactiseal, and DuraSeal.
## International Growth
International specialty surgery revenue grew 7.8% with improved product availability across multiple geographies.
## Tissue Reconstruction
Tissue reconstruction revenue declined 2.2% due to competitive pressure in urinary bladder matrix portfolio.
## Cincinnati Impact
Cincinnati flooding caused $7 million in lost revenue with $15-$20 million expected impact in Q4.
## Debt Refinancing
Completed $2.1 billion debt refinancing on Oct 19, 2026, including $1.65 billion credit facility and $450 million notes.
## Full Year Guidance
Full year 2026 revenue guidance updated to $1.634 billion-$1.654 billion with adjusted EPS of $2.30-$2.40.
## Operating Cash Flow
Operating cash flow reached $96 million, a record for Q3 driven by lower Braintree startup costs.
## Adjusted Gross Margin
Adjusted gross margin fell to 61.1% from 62.9% in prior year due to Cincinnati disruption.
## Debt Repayment
Debt repayment of $46 million reduced net debt to $1.5 billion at Q3 end.
## SurgiMend Relaunch
SurgiMend relaunch planned for December 2026 with expanded label for breast reconstruction in 2027.
## Tissue Reconstruction Recovery
PriMatrix sales remain above 50% of historical revenue levels supporting portfolio recovery.
## Interest Expense Impact
Expected $8 million incremental interest expense in Q4 and $24 million increase in 2027 due to refinancing.
## Cincinnati Recovery Timeline
Full manufacturing recovery expected by Q2 2027 with limited revenue contribution in Q2 2027.
## Key takeaway

Integra's Q3 revenue grew 2.5% organically to $411.2M despite $7M Cincinnati flood disruption, with full-year 2026 revenue guidance updated to $1.634B-$1.654B.